User-experience testing of an evidence-to-decision framework for selecting essential medicines
Essential medicine lists (EMLs) are important medicine prioritization tools used by the World
Health Organization (WHO) EML and over 130 countries. The criteria used by WHO's Expert …
Health Organization (WHO) EML and over 130 countries. The criteria used by WHO's Expert …
[HTML][HTML] Grading of recommendations, assessment, development and evaluations concept 7: issues and insights linking guideline recommendations to trustworthy …
Objectives Guidelines and essential medicine lists (EMLs) bear similarities and differences
in the process that lead to decisions. Access to essential medicines is central to achieve …
in the process that lead to decisions. Access to essential medicines is central to achieve …
Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study
N Abbasi Kasbi, S Ghane Ezabadi, K Kohandel… - BMC neurology, 2024 - Springer
Background Late-onset multiple sclerosis (LOMS), defined as the development of MS after
the age of 50, has shown a substantial surge in incidence rates and is associated with more …
the age of 50, has shown a substantial surge in incidence rates and is associated with more …
GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists
Objectives Guidelines and essential medicine lists (EMLs) bear similarities and differences
in the process that lead to decisions. Access to essential medicines is central to achieve …
in the process that lead to decisions. Access to essential medicines is central to achieve …
Recommendations for essential medicines for multiple sclerosis in low-resource settings
D Saylor, N Rijke, J McDonell… - Multiple Sclerosis …, 2024 - journals.sagepub.com
Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous
system that, when untreated, can lead to significant disability in young adults. Despite the …
system that, when untreated, can lead to significant disability in young adults. Despite the …
Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
M Li, N Zhou, S Duan, H Zhong, R Jiang, N Yuan - BMJ open, 2022 - bmjopen.bmj.com
Objective To compare the burden of multiple sclerosis disease indicators in the Asia-Pacific
countries, China and globally through the Global Burden of Disease 2019 (GBD2019) …
countries, China and globally through the Global Burden of Disease 2019 (GBD2019) …
Esclerose múltipla e as novas abordagens terapêuticas
MCS Sousa - 2023 - search.proquest.com
A esclerose múltipla é uma doença crónica, auto-imune, inflamatória e neurodegenerativa
que afeta o sistema nervoso central. Nesta doença, o sistema imunitário não reconhece …
que afeta o sistema nervoso central. Nesta doença, o sistema imunitário não reconhece …
[HTML][HTML] Latent microbial infections leading to myelin and axonal damage in multiple sclerosis: A narrative review
F Nezam Zadeh, A Esmaeilkhani, M Sedighi… - Current Journal of …, 2024 - cjn.tums.ac.ir
Background: Multiple sclerosis (MS) is a complex autoimmune disease characterized by
chronic inflammation, demyelination, and axonal damage in the central nervous system …
chronic inflammation, demyelination, and axonal damage in the central nervous system …
[HTML][HTML] Determining Effectiveness of “Off-Label Therapies” for Multiple Sclerosis in a Real-World Setting
L Pandit, S Mustafa, A Sudhir, P Malapur… - Annals of Indian …, 2024 - journals.lww.com
Objective: To determine the factors, if any, that are associated with the efficacy of “off-label
therapies”(OLTs) for multiple sclerosis (MS). Methods: Consecutive patients (N= 174) with …
therapies”(OLTs) for multiple sclerosis (MS). Methods: Consecutive patients (N= 174) with …
[PDF][PDF] Latent microbial infections leading to myelin and axonal damage in multiple sclerosis: A narrative review
FN Zadeh, A Esmaeilkhani, M Sedighi, N Amirmozafari… - 2024 - cjn.tums.ac.ir
Background: Multiple sclerosis (MS) is a complex autoimmune disease characterized by
chronic inflammation, demyelination, and axonal damage in the central nervous system …
chronic inflammation, demyelination, and axonal damage in the central nervous system …